We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Experimental Drug MK-4482 for COVID-19 Is Effective in Hamster Study

News   Apr 19, 2021 | Original story from National Institute of Allergy and Infectious Diseases

 
Experimental Drug MK-4482 for COVID-19 Is Effective in Hamster Study

This scanning electron microscope image shows SARS-CoV-2 (orange), the virus that causes COVID-19, isolated from a patient in the U.S. The virus is emerging from the surface of cells (gray) cultured in the lab. Image captured and colorized at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, Montana. Credit: NIAID

 
 
Advertisement
 

RELATED ARTICLES

Dual Vaccination Prevents Allergic Asthma in New Mouse Study

News

Promising results in a mouse model could point the way to the development of a therapy to treat half of all asthma cases.

READ MORE

Gene Therapy for Children Born Without an Immune System

News

An investigational gene therapy can safely restore the immune systems of infants and children who have a rare, life-threatening inherited immunodeficiency disorder, according to research supported in part by the National Institutes of Health.

READ MORE

Cholesterol Control Could Reduce Chronic Pain After Chemotherapy

News

Researchers have used a mouse model to demonstrate the pivotal role of cholesterol in chemotherapy-induced peripheral neuropathy and proposed a novel therapeutic approach to reverse it.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE